OpenAlex
PricingAboutJobs
Log inGet started
Work

Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically

HTML

Year: 2019
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-18-1394
Authors: Lucy C. Riches, Antonio G. Trinidad, Gareth Hughes, Gemma N. Jones, Adina M. Hughes, Andrew G. Thomason, Paul Gavine, Andy Cui, Stephanie Ling, Jonathan Stott, Roger Clark, Samantha Peel, Pendeep Gill, Louise M. Goodwin, Aaron Smith, Kurt G. Pike, Bernard Barlaam, Martin Pass, Mark J. O'Connor, Graeme Smith, Elaine B. Cadogan
Institution: AstraZeneca (United Kingdom)
Language: English

Topic: PARP inhibition in cancer therapy
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: AZD0156, ATM kinase inhibitor, radiosensitization, olaparib, PARP inhibitor combination, DNA double-strand break repair, DNA damage response, ATM signaling, triple-negative breast cancer, lung cancer, gastric cancer, cell cycle arrest, apoptosis, patient-derived xenografts
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W2974068148
FWCI: 8.458
Cites: 38
Cited by: 176
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security